TFIIH operates through an expanded proximal promoter to fine-tune c-myc expression

Molecular and Cellular Biology

Volumn 25, Issue 1, 2005, Pages 147-161

  Weber, Achim ^a,b   Liu, Juhong ^a   Collins, Irene ^a   Levens, David ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR IIH;

ARTICLE; CELL COMPOSITION; CELL FUNCTION; CELL STRUCTURE; COMPARATIVE STUDY; GENE EXPRESSION; HOMEOSTASIS; KINETICS; NOISE; ONCOGENE C MYC; PIGMENTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

BLOTTING, WESTERN; CELL CYCLE; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; DNA HELICASES; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; FIBROBLASTS; FLOW CYTOMETRY; GENETIC COMPLEMENTATION TEST; GREEN FLUORESCENT PROTEINS; HUMANS; KINETICS; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; MODELS, GENETIC; MUTATION; PLASMIDS; POTASSIUM PERMANGANATE; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-MYC; RIBONUCLEASES; RNA, MESSENGER; TRANSCRIPTION FACTOR TFIIH; TRANSCRIPTION FACTORS, TFII; TRANSFECTION; ULTRAVIOLET RAYS;

EID: 11144274567     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.25.1.147-161.2005     Document Type: Article

References (77)

1. Amundson, S. A., Q. Zhan, L. Z. Penn, and A. J. Fornace. 1998. Myc suppresses induction of the growth arrest genes gadd34, gadd45, and gadd153 by DNA-damaging agents. Oncogene 17:2149-2154.
2. Chambers, A. E., S. Banerjee, T. Chaplin, J. Dunne, S. Debernardi, S. P. Joel, and B. D. Young. 2003. Histone acetylation-mediated regulation of genes in leukaemic cells. Eur. J. Cancer 39:1165-1175.
3. Chen, D., T. Riedl, E. Washbrook, P. E. Pace, R. C. Coombes, J. M. Egly, and S. Ali. 2000. Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7. Mol. Cell 6:127-137.
4. Coin, F., E. Bergmann, A. Tremeau-Bravard, and J. M. Egly. 1999. Mutations in XPB and XPD helicases found in xeroderma pigmentosum patients impair the transcription function of TFIIH. EMBO J. 18:1357-1366.
5. Coin, F., and J. M. Egly. 1998. Ten years of TFIIH. Cold Spring Harb. Symp. Quant. Biol. 63:105-110.
6. Collins, I., A. Weber, and D. Levens. 2001. Transcriptional consequences of topoisomerase inhibition. Mol. Cell. Biol. 21:8437-8451.
7. Cramer, P. 2002. Multisubunit RNA polymerases. Curr. Opin. Struct. Biol. 12:89-97.
8. Dani, C., N. Mechti, M. Piechaczyk, B. Lebleu, P. Jeanteur, and J. M. Blanchard. 1985. Increased rate of degradation of c-myc messenger-RNA in interferon-treated Daudi cells. Proc. Natl. Acad. Sci. USA 82:4896-4899.
9. Dubaele, S., L. Proietti De Santis, R. J. Bienstock, A. Keriel, M. Stefanini, B. Van Houten, and J. M. Egly. 2003. Basal transcription defect discriminates between xeroderma pigmentosum and trichothiodystrophy in XPD patients. Mol. Cell 11:1635-1646.
10. Duncan, R., L. Bazar, G. Michelotti, T. Tomonaga, H. Krutzsch, M. Avigan, and D. Levens. 1994. A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif. Genes Dev. 8:465-480.
11. Dvir, A., S. Tan, J. W. Conaway, and R. C. Conaway. 1997. Promoter escape by RNA polymerase II. Formation of an escape-competent transcriptional intermediate is a prerequisite for exit of polymerase from, the promoter. J. Biol. Chem. 272:28175-28178.
12. Egly, J. M. 2001. The 14th Datta lecture. TFIIH: from transcription to clinic. FEBS Lett. 498:124-128.
13. Elowitz, M. B., A. J. Levine, E. D. Siggia, and P. S. Swain. 2002. Stochastic gene expression in a single cell. Science 297:1183-1186.
14. Ferguson, H. A., J. F. Kugel, and J. A. Goodrich. 2001. Kinetic and mechanistic analysis of the RNA polymerase II transcription reaction at the human interleukin-2 promoter. J. Mol. Biol. 314:993-1006.
15. Feynman, R., R. Leighton, and M. Sands. 1989. The Feynman lectures on physics: commemorative issue, vol. I. Addison-Wesley, Reading, Pa.
16. Fukuda, A., Y. Nogi, and K. Hisatake. 2002. The regulatory role for the ERCC3 helicase of general transcription factor TFIIH during promoter escape in transcriptional activation. Proc. Natl. Acad. Sci. USA 99:1206-1211.
17. Garmyn, M., M. Yaar, N. Holbrook, and B. A. Gilchrest. 1991. Immediate and delayed molecular response of human keratinocytes to solar-simulated irradiation. Lab. Investig. 65:471-478.
18. Giardina, C., M. Perez-Riba, and J. T. Lis. 1992. Promoter melting and TFIID complexes on Drosophila genes in vivo. Genes Dev. 6:2190-2200.
19. Goodrich, J. A., and R. Tjian. 1994. Transcription factors HE and UH and ATP hydrolysis direct promoter clearance by RNA polymerase II. Cell. 77:145-156.
20. Gozukara, E. M., C. N. Parris, C. A. Weber, E. P. Salazar, M. M. Seidman, J. F. Watkins, L. Prakash, and K. H. Kraemer. 1994. The human DNA repair gene, ERCC2 (XPD), corrects ultraviolet hypersensitivity and ultraviolet hypermutability of a shuttle vector replicated in xeroderma pigmentosum group D cells. Cancer Res. 54:3837-3844.
21. Greenblatt, J., and C. J. Ingles. 1996. Interaction between acidic transcriptional activation domains of herpes simplex virus activator protein VP16 and transcriptional initiation factor UD. Methods Enzymol. 274:120-133.
22. Hann, S. R., and R. N. Eisenman. 1984. Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells. Mol. Cell. Biol. 4:2486-2497.
23. Haviv, I., D. Vaizel, and Y. Shaul. 1996. pX, the HBV-encoded coactivator, interacts with components of the transcription machinery and stimulates transcription in a TAF-independent manner. EMBO J. 15:3413-3420.
24. He, L., J. Liu, I. Collins, S. Sanford, B. O'Connell, C. J. Benham, and D. Levens. 2000. Loss of FBP function arrests cellular proliferation and extinguishes c-myc expression. EMBO J. 19:1034-1044.
25. Holstege, F. C., U. Fiedler, and H. T. Timmers. 1997. Three transitions in the RNA polymerase II transcription complex during initiation. EMBO J. 16:7468-7480.
26. Holstege, F. C., P. C. van der Vliet, and H. T. Timmers. 1996. Opening of an RNA polymerase II promoter occurs in two distinct steps and requires the basal transcription factors IIE and IIH. EMBO J. 15:1666-1677.
27. Hwang, J. R., V. Moncollin, W. Vermeulen, T. Seroz, H. van Vuuren, J. H. J. Hoeijmakers, and J. M. Egly. 1996. A 3′ → 5′ XPB helicase defect in repair/transcription factor TFIIH of xeroderma pigmentosum group B affects both DNA repair and transcription. J. Biol. Chem. 271:15898-15904.
28. Iben, S., H. Tschochner, M. Bier, D. Hoogstraten, P. Hozak, J. M. Egly, and I. Grummt. 2002. TFIIH plays an essential role in RNA polymerase I transcription. Cell 109:297-306.
29. Keath, E. J., A. Kelekar, and M. D. Cole. 1984. Transcriptional activation of the translocated c-myc oncogene in mouse plasmacytomas: similar RNA levels in tumor and proliferating normal cells. Cell 37:521-528.
30. Keriel, A., A. Stary, A. Sarasin, C. Rochette-Egly, and J. M. Egly. 2002. XPD mutations prevent TFIIH-dependent transactivation by nuclear receptors and phosphorylation of RARα. Cell 109:125-135.
31. Kim, T. K., R. H. Ebright, and D. Reinberg. 2000. Mechanism of ATP-dependent promoter melting by transcription factor IIH. Science 288:1418-1422.
32. Komarnitsky, P., E. J. Cho, and S. Buratowski. 2000. Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription. Genes Dev. 14:2452-2460.
33. Kugel, J. F., and J. A. Goodrich. 2000. A kinetic model for the early steps of RNA synthesis by human RNA polymerase II. J. Biol. Chem. 275:40483-40491.
34. Kugel, J. F., and J. A. Goodrich. 1998. Promoter escape limits the rate of RNA polymerase II transcription and is enhanced by TFIIE, TFIIH, and ATP on negatively supercoiled DNA. Proc. Natl. Acad. Sci. USA 95:9232-9237.
35. Kumar, K. P., S. Akoulitchev, and D. Reinberg. 1998. Promoter-proximal stalling results from the inability to recruit transcription factor IIH to the transcription complex and is a regulated event. Proc. Natl. Acad. Sci. USA 95:9767-9772.
36. Landick, R. 2004. Active-site dynamics in RNA polymerases. Cell 116:351-353.
37. Levens, D. 2002. Disentangling the MYC web. Proc. Natl. Acad. Sci. USA 99:5757-5759.
38. Levens, D. L. 2003. Reconstructing MYC. Genes. Dev. 17:1071-1077.
39. Levsky, J. M., and R. H. Singer. 2003. Gene expression and the myth of the average cell. Trends Cell Biol. 13:4-6.
40. Liu, J., L. He, I. Collins, H. Ge, D. Libutti, J. Li, J. M. Egly, and D. Levens. 2000. The FBP interacting repressor targets TFIIH to inhibit activated transcription. Mol. Cell 5:331-341.
41. Liu, J. H., S. Akoulitchev, A. Weber, H. Ge, S. Chuikov, D. Libutti, X. W. Wang, J. W. Conaway, C. C. Harris, R. C. Conaway, D. Reinberg, and D. Levens. 2001. Defective interplay of activators and repressors with TFIIH in xeroderma pigmentosum. Cell 104:353-363.
42. Lomvardas, S., and D. Thanos. 2002. Modifying gene expression programs by altering core promoter chromatin architecture. Cell 110:261-271.
43. Lu, H., R. P. Fisher, P. Bailey, and A. J. Levine. 1997. The CDK7-cycH-p36 complex of transcription factor IIH phosphorylates p53, enhancing its sequence-specific DNA binding activity in vitro. Mol. Cell. Biol. 17:5923-5934.
44. Marcu, K. B., S. A. Bossone, and A. J. Patel. 1992. myc function and regulation. Annu. Rev. Biochem. 61:809-860.
45. Michelotti, E. F., S. Sanford, and D. Levens. 1997. Marking of active genes on mitotic chromosomes. Nature 388:895-899.
46. Michelotti, G. A., E. F. Michelotti, A. Pullner, R. C. Duncan, D. Eick, and D. Levens. 1996. Multiple single-stranded cis elements are associated with activated chromatin of the human c-myc gene in vivo. Mol. Cell. Biol. 16:2656-2669.
47. Moberg, K. H., W. A. Tyndall, and D. J. Hall. 1992. Wild-type murine p53 represses transcription from the murine c-myc promoter in a human glial cell line. J. Cell Biochem. 49:208-215.
48. Moreland, R. J., F. Tirode, Q. Yan, J. W. Conaway, J. M. Egly, and R. C. Conaway. 1999. A role for the TFIIH XPB DNA helicase in promoter escape by RNA polymerase II. J. Biol. Chem. 274:22127-22130.
49. Mueller, P. R., and B. Wold. 1989. In vivo footprinting of a muscle specific enhancer by ligation mediated PCR. Science 246:780-786.
50. Ostapenko, D., and O. Gileadi. 2000. Rad25p, a DNA helicase subunit of yeast transcription factor TFIIH, is required for promoter escape in vivo. Gene 245:109-117.
51. Pal, M., and D. S. Luse. 2002. Strong natural pausing by RNA polymerase II within 10 bases of transcription start may result in repeated slippage and reextension of the nascent RNA. Mol. Cell. Biol. 22:30-40.
52. Pal, M., D. McKean, and D. S. Luse. 2001. Promoter clearance by RNA polymerase II is an extended, multistep process strongly affected by sequence. Mol. Cell. Biol. 21:5815-5825.
53. Parvin, J. D., and P. A. Sharp. 1993. DNA topology and a minimal set of basal factors for transcription by RNA polymerase II. Cell 73:533-540.
54. Rabbitts, P. H., J. V. Watson, A. Lamond, A. Forster, M. A. Stinson, G. Evan, W. Fischer, E. Atherton, R. Sheppard, and T. H. Rabbitts. 1985. Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle. EMBO J. 4:2009-2015.
55. Raser, J. M., and E. K. O'Shea. 2004. Control of stochasticity in eukaryotic gene expression. Science 304:1811-1814.
56. Rougvie, A. E., and J. T. Lis. 1988. The RNA polymerase II molecule at the 5′ end of the uninduced hsp70 gene of D. melanogaster is transcriptionally engaged. Cell 54:795-804.
57. Saez, A. I., M. J. Artiga, C. Romero, S. Rodriguez, J. C. Cigudosa, A. Perez-Rosado, I. Fernandez, M. Sanchez-Beato, E. Sanchez, M. Mollejo, and M. A. Piris. 2003. Development of a leal-time reverse transcription polymerase chain reaction assay for c-myc expression that allows the identification of a subset of c-myc plus diffuse large B-cell lymphoma. Lab. Investig. 83:143-152.
58. Sakurai, H., N. Hashikawa, H. Imazu, and T. Fukasawa. 2003. Carboxy-terminal region of the yeast heat shock factor contains two domains that make transcription independent of the TFIIH protein kinase. Genes Cells 8:951-961.
59. Schneider, E., M. Montenarh, and P. Wagner. 1998. Regulation of CAK kinase activity by p53. Oncogene 17:2733-2741.
60. Schwartz, B. E., S. Larochelle, B. Suter, and J. T. Lis. 2003. Cdk7 is required for full activation of Drosophila heat shock genes and RNA polymerase II phosphorylation in vivo. Mol. Cell. Biol. 23:6876-6886.
61. Sears, R., F. Nuckolls, E. Haura, Y. Taya, K. Tamai, and J. R. Nevins. 2000. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev. 14:2501-2514.
62. Spangler, L., X. Wang, J. W. Conaway, R. C. Conaway, and A. Dvir. 2001. TFIIH action in transcription initiation and promoter escape requires distinct regions of downstream promoter DNA. Proc. Natl. Acad. Sci. USAProc 98:5544-5549.
63. Spencer, C. A., and M. Groudine. 1991. Control of c-myc regulation in normal and neoplastic cells. Adv. Cancer Res. 56:1-48.
64. Svejstrup, J. Q., P. Vichi, and J. M. Egly. 1996. The multiple roles of transcription/repair factor TFIIH. Trends Biochem. Sci. 21:346-350.
65. Tahirov, T. H., D. Temiakov, M. Anikin, V. Patlan, W. T. McAllister, D. G. Vassylyev, and S. Yokoyama. 2002. Structure of a T7 RNA polymerase elongation complex at 2.9 A resolution. Nature 420:43-50.
66. Thanos, D., and T. Maniatis. 1995. Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell 83:1091-1100.
67. Tong, X., R. Drapkin, D. Reinberg, and E. Kieff. 1995. The 62- and 80-kDa subunits of transcription factor IIH mediate the interaction with Epstein-Barr virus nuclear protein 2. Proc. Natl. Acad. Sci. USA 92:3259-3263.
68. Trigon, S., H. Serizawa, J. W. Conaway, R. C. Conaway, S. P. Jackson, and M. Morange. 1998. Characterization of the residues phosphorylated in vitro by different C-terminal domain kinases. J. Biol. Chem. 273:6769-6775.
69. Trumpp, A., Y. Refaeli, T. Oskarsson, S. Gasser, M. Murphy, G. R. Martin, and J. M. Bishop. 2001. c-Myc regulates mammalian body size by controlling cell number but not cell size. Nature 414:768-773.
70. Van Lint, C., S. Emiliani, and E. Verdin. 1996. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr. 5:245-253.
71. van Steeg, H., and K. H. Kraemer. 1999. Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer. Mol. Med. Today 5:86-94.
72. Viprakasit, V., R. J. Gibbons, B. C. Broughton, J. L. Tolmie, D. Brown, P. Lunt, R. M. Winter, S. Marinoni, M. Stefanini, L. Brueton, A. R. Lehmann, and D. R. Higgs. 2001. Mutations in the general transcription factor TFIIH result in beta-thalassaemia in individuals with trichothiodystrophy. Hum. Mol. Genet. 10:2797-2802.
73. Weinmann, A. S., and P. J. Farnham. 2002. Identification of unknown target genes of human transcription factors using chromatin immunoprecipitation. Methods 26:37-47.
74. Winkler, G. S., W. Vermeulen, F. Coin, J. M. Egly, J. H. Hoeijmakers, and G. Weeda. 1998. Affinity purification of human DNA repair/transcription factor TFIIH using epitope-tagged xeroderma pigmentosum B protein. J. Biol. Chem. 273:1092-1098.
75. Wolf, D. A., L. J. Strobl, A. Pullner, and D. Eick. 1995. Variable pause positions of RNA polymerase II lie proximal to the c-myc promoter irrespective of transcriptional activity. Nucleic Acids Res. 23:3373-3379.
76. Xiao, H., A. Pearson, B. Coulombe, R. Truant, S. Zhang, J. L. Regier, S. J. Triezenberg, D. Reinberg, O. Flores, and C. J. Ingles. 1994. Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53. Mol. Cell. Biol. 14:7013-7024.
77. Yin, Y. W., and T. A. Steitz. 2002. Structural basis for the transition from initiation to elongation transcription in T7 RNA polymerase. Science 298:1387-1395.